Media Coverage

A Shifting Drug Development Landscape Amid COVID-19 Crisis

A Shifting Drug Development Landscape Amid COVID-19 Crisis

Contract Pharma

Discovery and development of complex or combination molecules, biologics, vaccines and other innovative therapies require more sophisticated analytical, bioanalytical and immunology services. As demand for challenging assays and custom solutions increases – particularly during the COVID-19 pandemic – providing the right support and tools is increasingly important.

Read the full article